Bortezomib (Velcade®) ( DrugBank: Bortezomib )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 66 | IgA腎症 | 1 |
66. IgA腎症
臨床試験数 : 275 / 薬物数 : 258 - (DrugBank : 82) / 標的遺伝子数 : 36 - 標的パスウェイ数 : 140
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01103778 (ClinicalTrials.gov) | July 2010 | 13/4/2010 | Pilot Study of Velcade® in IgA Nephropathy | Velcade Therapy for Severe IgA Nephropathy | Chronic Kidney Disease;IgA Nephropathy | Drug: Bortezomib (Velcade®) | The Rogosin Institute | Weill Medical College of Cornell University | Completed | 18 Years | N/A | All | 11 | Phase 4 | United States |